.: Impact of machine learning and feature selection on type 2 diabetes risk prediction. J. Med. Artif. Intell. 3, 1–6 (2020) 23. Shah, F., Kendall, P ., Khozin, N., Goosen, S., Hu, R., Laramie, J., Ringel, J., Schork, M.: Artiﬁcial intelligence and machine learning in clinical development: a translational perspective.npj Digit. Med. 2, 69 (2019) 24. Abbod, M.F., Linkens, D.A., Mahfouf, M., Dounias, G.: Survey on the use of smart and adaptive engineering systems in medicine. Artif. Intell. Med. 26(3), 179–209 (2002) 25. Mak, K.K., Pichika, M.R.: Artiﬁcial intelligence in drug development: present status and future prospects. Drug Discov. Today.